OxTalks will soon be transitioning to Oxford Events (full details are available on the Staff Gateway). A two-week publishing freeze is expected in early Hilary to allow all events to be migrated to the new platform. During this period, you will not be able to submit or edit events on OxTalks. The exact freeze dates will be confirmed as soon as possible.
If you have any questions, please contact halo@digital.ox.ac.uk
Professor Lou Garrison will give a whistle-stop tour de force of his many years of work at the interface of innovation markets and innovation value to healthcare systems and patients. He will delve into his international work on evolving value frameworks in rethinking how we capture and assess the value of innovation, beyond the economic value via concepts of productivity, spillover and equity value. He will cast a critical eye over cost effectiveness analysis and access against the rapidly changing political backdrop of governments grappling with health care cost containment.
This talk is part of the Economics and Regulation in Translational Science course, which forms part of the Translational Health Sciences programme. This event is free and open to all.
About the speaker
Lou Garrison, PhD, is Professor Emeritus in The Comparative Health Outcomes, Policy, and Economics Institute in the School of Pharmacy at the University of Washington, where he joined the faculty in 2004. He is also a Visiting Senior Fellow at the Office of Health Economics in London following his sabbatical there in 2012-13.
Professor Garrison received a PhD in Economics from Stanford University and has more than 200 publications in peer-reviewed journals.
For the first 13 years of his career, he worked in non-profit health policy. Following this, he worked as an economist in the pharmaceutical industry for 12 years.
His research interests include national and international health policy issues related to health technology assessment, personalized medicine, benefit-risk analysis, and other topics, as well as the economic evaluation and pricing of biopharmaceuticals, diagnostics, and other technologies.
Professor Garrison was elected as ISPOR President for July 2016-June 2017. He has served as co-chair of ISPOR’s Policy Outlook Committee for Health Science Policy Council, and he is currently a leader of the ISPOR Special Interest Group on Global Access to Medical Innovation. In September 2022, he received the Avedis Donabedian Outcomes Research Lifetime Achievement Award from ISPOR.
